5.10Delayed Data As of 4:00pm ET | +0.05 / +0.99%Today’s Change | 3.60 Today|||52-Week Range 6.15 | +18.60% Year-to-Date |
SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $494.7M |
Company Description
Accuray, Inc. is a radiation oncology company. It develops, manufactures and sells precise, innovative treatment solutions, which include cyberKnife and tomo therapy systems, which are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The cyberKnife system is designed to combine continual image guidance technology with a compact linear accelerator, or linac, which has the ability to move in three dimensions according to the treatment plan. The tomotherapy system operates on a ring gantry and combines integrated computed tomography, or CT, imaging with intensity modulated radiation therapy, which is designed to deliver radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.
Employees

Shareholders
Other institutional | 43.55% |
Mutual fund holders | 40.88% |
Individual stakeholders | 30.27% |
Top Executives
Joshua H. Levine | President, Chief Executive Officer & Director |
Andrew J. Kirkpatrick | SVP-Global Operations, Research & Development |
Kevin Waters | Chief Financial Officer & Senior Vice President |
Darl S. Moreland | Senior VP-Regulatory, Quality & Compliance |
Alaleh Nouri | Secretary, Senior Vice President & General Counsel |